Storage & handling

Why lyophilized and reconstituted peptides behave differently

Lyophilization (freeze-drying) removes water under vacuum, which suppresses the chemical pathways that degrade peptides — hydrolysis, oxidation, deamidation, and aggregation all require water as a reaction medium or transport mechanism. A peptide locked in a properly dried, glassy solid state is dramatically more stable than the same peptide in solution. The moment water is reintroduced (reconstitution), those degradation pathways reactivate immediately, and a measurable fraction of total degradation for a reconstituted peptide tends to happen in the first 72 hours before settling into a slower steady-state rate.

Lyophilized (powder) storage

• −80 °C: longest-lived storage, commonly cited at 3–5+ years for most sequences.
• −20 °C (freezer): the standard long-term recommendation; most lyophilized peptides hold up for 1–3 years.
• 2–8 °C (refrigerator): acceptable for active-use vials, typically 12–24 months depending on sequence.
• Room temperature: generally tolerated for weeks to a few months if the seal is intact and the vial is dry and dark, but not recommended for anything beyond short transit.
• Heat tolerance in transit: most lyophilized peptides tolerate brief excursions up to ~37–40 °C without meaningful degradation, which is why vendors ship powder without cold packs. This is not true once reconstituted.
• Humidity is the main threat to powder, not heat. Moisture entry — repeated needle punctures, an imperfect seal, opening a cold vial and letting it “sweat” — rehydrates the cake and restarts degradation chemistry even before deliberate reconstitution.
• Light degrades light-sensitive residues (tryptophan, tyrosine) and, separately, photolytically damages metal-complexed peptides like GHK-Cu.

Reconstituted (liquid) storage

Always 2–8 °C, never frozen. Freezing a reconstituted peptide forms ice crystals that mechanically disrupt the folded or complexed structure — this is consistently flagged across every source as a hard rule, not a preference.

Diluent matters enormously:

• Bacteriostatic water (0.9% benzyl alcohol preservative) — extends usable refrigerated life to the commonly cited ~28 days, because the preservative controls microbial growth in the vial, not because it changes the peptide's chemistry.
• Plain sterile water (no preservative) — no antimicrobial protection, so usable life drops to roughly 24–48 hours regardless of how chemically stable the peptide itself is.

This bacteriostatic-versus-sterile distinction has a strong real-world parallel in an FDA-labeled product: lyophilized GM-CSF (Leukine) is good for ~6 hours after reconstitution with plain sterile water for injection, but up to 20 days at 2–8 °C when reconstituted with bacteriostatic water — same molecule, same temperature, very different shelf life, purely because of the preservative.

Freeze-thaw cycling is cumulative damage. Each cycle promotes aggregation; the standard mitigation is aliquoting immediately after reconstitution so each portion is only thawed once.

Arrhenius rule of thumb: every 10 °C rise roughly doubles the rate of chemical degradation, which is why “left out on the counter overnight” is a meaningfully bigger event than it sounds.

Beyond-use dating (BUD) and USP <795>/<797>

Once a peptide is reconstituted or compounded for administration, the handling falls squarely into USP <795>/<797> territory — the same beyond-use-dating framework pharmacies use for any compounded sterile preparation. An expiration date is manufacturer-assigned from real stability data on the unopened product; a beyond-use date (BUD) is what a pharmacist (or, in the research-peptide world, a vendor) assigns to something once it has been opened, mixed, or compounded — and it is allowed to be more conservative than the label but never less. The commonly repeated “28 days” number for reconstituted research peptides is derived from the bacteriostatic water preservative's antimicrobial validation window, not from a per-peptide chemical stability study.

How this site labels storage evidence

Every peptide article's Storage & handling section carries one of three evidence tags so readers can calibrate how confident to be in the numbers:

• Regulatory label — the storage numbers come from an FDA-approved prescribing information, DailyMed label, or manufacturer medical-information page. Highest confidence.
• Vendor consensus — multiple independent peptide vendors and compounding-pharmacy sources agree on a number, but no peer-reviewed or regulatory source specific to this compound was located. Reasonable orientation; not FDA-label-grade.
• General framework only (no badge shown) — no compound-specific stability data has been identified for this peptide, and the section shows a pointer back to this page rather than made-up numbers.

References

Regulatory / official: Novo Nordisk Medical GLP-1 RA storage & stability page; FDA prescribing information / DailyMed labels via accessdata.fda.gov; NCI trial protocol referencing the Leukine (sargramostim) reconstitution table; Pharmacy Times editorial “As Peptides Go Mainstream, USP <795> and <797> Matter More Than Ever”; ASHP “The Pharmacist Guide to Assigning a Beyond Use Date.”

Vendor / compounding-pharmacy consensus is drawn from multiple independent sources including Durham Peptides, Palmetto Peptides, SeekPeptides, and others — see the per-peptide References section on any article for the exact sources cited for that compound.